Skip to main content
Skip to navigation

All HLA-B*13:01 biomarker articles

News
A*STAR spin-off NalaGenetics implements nationwide drug reaction screening for leprosy patients in Indonesia

2025-02-27T10:22:00Z

NalaGenetics, a spin-off from A*STAR Genome Institute of Singapore (A*STAR GIS), will be transforming leprosy treatments in Indonesia with a nationwide genetic screening programme with their PGx1301 diagnostic kit.